| Ovarian cancer: epidemiology, biology, and prognostic factors CH Holschneider, JS Berek Seminars in surgical oncology 19 (1), 3-10, 2000 | 1103 | 2000 |
| Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations R Salani, FJ Backes, MFK Fung, CH Holschneider, LP Parker, RE Bristow, ... American journal of obstetrics and gynecology 204 (6), 466-478, 2011 | 472 | 2011 |
| Incisional hernia following laparoscopy: a survey of the American Association of Gynecologic Laparoscopists FJ Montz, CH Holschneider, MG Munro OBSTETRICS AND GYNECOLOGY-NEW YORK- 84, 881-881, 1994 | 413 | 1994 |
| Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: report of seven cases and review of the literature YB Kim, CH Holschneider, K Ghosh, RK Nieberg, FJ Montz Cancer 79 (2), 320-327, 1997 | 315 | 1997 |
| Coexisting ovarian malignancy in young women with endometrial cancer C Walsh, C Holschneider, Y Hoang, K Tieu, B Karlan, I Cass Obstetrics & Gynecology 106 (4), 693-699, 2005 | 306 | 2005 |
| Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer AE Axtell, MH Lee, RE Bristow, SC Dowdy, WA Cliby, S Raman, ... Journal of clinical oncology 25 (4), 384-389, 2007 | 291 | 2007 |
| Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment GD Aletti, EL Eisenhauer, A Santillan, A Axtell, G Aletti, C Holschneider, ... Gynecologic oncology 120 (1), 23-28, 2011 | 264 | 2011 |
| BRCA-mutation–associated fallopian tube carcinoma: a distinct clinical phenotype? I Cass, C Holschneider, N Datta, D Barbuto, AE Walts, BY Karlan Obstetrics & Gynecology 106 (6), 1327-1334, 2005 | 188 | 2005 |
| Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline J Chino, CM Annunziata, S Beriwal, L Bradfield, BA Erickson, EC Fields, ... Practical radiation oncology 10 (4), 220-234, 2020 | 168 | 2020 |
| Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy A Karam, N Feldman, CH Holschneider Nature Clinical Practice Oncology 4 (6), 375-380, 2007 | 123 | 2007 |
| Brachytherapy: a critical component of primary radiation therapy for cervical cancer: from the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS) CH Holschneider, DG Petereit, C Chu, IC Hsu, YJ Ioffe, AH Klopp, ... Brachytherapy 18 (2), 123-132, 2019 | 112 | 2019 |
| Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers J Wang, C Wieslander, G Hansen, I Cass, S Vasilev, CH Holschneider Gynecologic oncology 101 (1), 120-125, 2006 | 112 | 2006 |
| Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer R Salani, A Axtell, M Gerardi, C Holschneider, RE Bristow Gynecologic oncology 108 (2), 271-275, 2008 | 108 | 2008 |
| The modified Pereyra procedure in recurrent stress urinary incontinence: a 15-year review CH Holschneider, S Solh, TB Lebherz, FJ Montz Obstetrics & Gynecology 83 (4), 573-578, 1994 | 107 | 1994 |
| Large-loop excision of the transformation zone: effect on the pathologic interpretation of resection margins FJ Montz, CH Holschneider, LDR Thompson Obstetrics & Gynecology 81 (6), 976-982, 1993 | 99 | 1993 |
| FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival S Memarzadeh, CH Holschneider, RE Bristow, NL Jones, YS Fu, ... International Journal of Gynecologic Cancer 12 (5), 2002 | 80 | 2002 |
| Small bowel obstruction following radical hysterectomy: risk factors, incidence, and operative findings FJ Montz, CH Holschneider, S Solh, LC Schuricht, BJ Monk Gynecologic oncology 53 (1), 114-120, 1994 | 80 | 1994 |
| Vulvar intraepithelial neoplasia: risk factors for recurrence W Satmary, CH Holschneider, LL Brunette, S Natarajan Gynecologic oncology 148 (1), 126-131, 2018 | 72 | 2018 |
| See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis CH Holschneider, K Ghosh, FJ Montz Obstetrics & Gynecology 94 (3), 377-385, 1999 | 72 | 1999 |
| Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy KR Penner, O Dorigo, C Aoyama, N Ostrzega, BL Balzer, J Rao, ... Gynecologic oncology 124 (3), 542-548, 2012 | 67 | 2012 |
